AD Publication in Action Evaluation (ID: i716a) Survey

Question Title

* 1. After your participation in this activity, how confident are you in the management of patients with AD in your practice?

Very confident

Confident

Neutral

Unconfident

Very unconfident

Question Title

* 2. Which of the following strategies do you use in practice in an effort to improve adherence to medications for atopic dermatitis? Check all that apply.

Written AD action plans

Multidisciplinary patient education

Discussion of patient concerns about treatment

Asking patients to choose preferred treatment vehicle

Question Title

* 3. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information that I can apply to my area of practice.

I need more information before I change my practice behavior.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes.

Question Title

* 5. As a result of your participation in this activity, what strategies/changes do you plan to implement in your practice?

Question Title

* 6. What barriers do you see to making changes in your practice?

Question Title

* 7. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 8. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Utilize updated criteria and guidelines to accurately diagnose AD and assess severity	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity Strongly agree	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity Agree	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity Neutral	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity Disagree	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity Strongly disagree
Describe the limitations of currently available therapies in addressing underlying AD pathophysiology	Describe the limitations of currently available therapies in addressing underlying AD pathophysiology Strongly agree	Describe the limitations of currently available therapies in addressing underlying AD pathophysiology Agree	Describe the limitations of currently available therapies in addressing underlying AD pathophysiology Neutral	Describe the limitations of currently available therapies in addressing underlying AD pathophysiology Disagree	Describe the limitations of currently available therapies in addressing underlying AD pathophysiology Strongly disagree
Evaluate recent clinical evidence on the utility of approved and emerging biologic agents to address the underlying pathophysiology of AD	Evaluate recent clinical evidence on the utility of approved and emerging biologic agents to address the underlying pathophysiology of AD Strongly agree	Evaluate recent clinical evidence on the utility of approved and emerging biologic agents to address the underlying pathophysiology of AD Agree	Evaluate recent clinical evidence on the utility of approved and emerging biologic agents to address the underlying pathophysiology of AD Neutral	Evaluate recent clinical evidence on the utility of approved and emerging biologic agents to address the underlying pathophysiology of AD Disagree	Evaluate recent clinical evidence on the utility of approved and emerging biologic agents to address the underlying pathophysiology of AD Strongly disagree
Discuss strategies that will improve patient satisfaction with treatment and reduce the burden of comorbidities	Discuss strategies that will improve patient satisfaction with treatment and reduce the burden of comorbidities Strongly agree	Discuss strategies that will improve patient satisfaction with treatment and reduce the burden of comorbidities Agree	Discuss strategies that will improve patient satisfaction with treatment and reduce the burden of comorbidities Neutral	Discuss strategies that will improve patient satisfaction with treatment and reduce the burden of comorbidities Disagree	Discuss strategies that will improve patient satisfaction with treatment and reduce the burden of comorbidities Strongly disagree

Question Title

* 9. Amy S. Paller, MS, MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 10. Jonathan M. Spergel, MD, PhD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 11. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 13. How would you rate the format of this activity?

Excellent

Average

Below average

Poor

Question Title

* 14. Would you be willing to participate in a postactivity follow-up survey?

Yes